Daniel S. Chen
Impact in
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 34
- Cancer Immunotherapy and Biomarkers 30
- CAR-T cell therapy research 11
- Immunology 19
- Immunotherapy and Immune Responses 15
- Immune cells in cancer 4
- Co-authors
- Ira Mellman (5 shared papers)Priti S. Hegde (12 shared papers)Rajendra S. Apte (1 shared paper)Napoleone Ferrara (1 shared paper)Thomas Powles (5 shared papers)F. Stephen Hodi (9 shared papers)Bryan Irving (3 shared papers)Gregg Fine (13 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Cancer Research (6 papers)Clinical Cancer Research (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)Immunity (3 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Daniel S. Chen
49 papers receiving 20.2k citations
Daniel S. Chen's Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 11.5k
- Immunology 7.6k
- Cancer Research 2.1k
- Pulmonary and Respiratory Medicine 3.3k
- Molecular Biology 4.5k
Countries citing papers authored by Daniel S. Chen
This map shows the geographic impact of Daniel S. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Chen more than expected).
Fields of papers citing papers by Daniel S. Chen
This network shows the impact of papers produced by Daniel S. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Chen. The network helps show where Daniel S. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel S. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oncology Meets Immunology: The Cancer-Immunity Cycle Hit paper breakdown → | 2013 | 4969 |
| 2 | Elements of cancer immunity and the cancer–immune set point Hit paper breakdown → | 2017 | 3686 |
| 3 | Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial Hit paper breakdown → | 2016 | 2139 |
| 4 | VEGF in Signaling and Disease: Beyond Discovery and Development Hit paper breakdown → | 2019 | 1943 |
| 5 | MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer Hit paper breakdown → | 2014 | 1860 |
| 6 | Top 10 Challenges in Cancer Immunotherapy Hit paper breakdown → | 2020 | 1499 |
| 7 | The cancer-immunity cycle: Indication, genotype, and immunotype Hit paper breakdown → | 2023 | 516 |
| 8 | Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1 Hit paper breakdown → | 2012 | 500 |
| 9 | Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure) Hit paper breakdown → | 2016 | 499 |
| 10 | 2006 | 346 | |
| 11 | 2018 | 245 | |
| 12 | 2010 | 239 | |
| 13 | 2012 | 199 | |
| 14 | 2015 | 170 | |
| 15 | 2013 | 157 | |
| 16 | 2018 | 155 | |
| 17 | 2012 | 155 | |
| 18 | 2011 | 149 | |
| 19 | 2013 | 139 | |
| 20 | 2003 | 119 |
About Daniel S. Chen
Daniel S. Chen is a scholar working on Oncology, Immunology, Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 50 papers that have together received 20.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (30 papers), Immunotherapy and Immune Responses (15 papers), CAR-T cell therapy research (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Bladder and Urothelial Cancer Treatments (6 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Genomics and Diagnostics (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Oncology (11.5k citations), Immunology (7.6k citations), Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (3.3k citations) and Molecular Biology (4.5k citations). Daniel S. Chen has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Ira Mellman, Priti S. Hegde, Rajendra S. Apte, Napoleone Ferrara, Thomas Powles, F. Stephen Hodi, Bryan Irving, Gregg Fine, Marcin Kowanetz and Marcus Ballinger. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.